Pulmonary defence mechanisms

Respiration

Volumn 66, Issue 1, 1999, Pages 2-11

  Nicod, Laurent P ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b Faculty of Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; OPSONIN; SECRETORY IMMUNOGLOBULIN;

CELLULAR IMMUNITY; CILIARY MOTILITY; COUGHING; DENDRITIC CELL; EOSINOPHIL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG INFECTION; LYMPHOID TISSUE; NEUTROPHIL; PARTICULATE MATTER; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA; REVIEW; T LYMPHOCYTE ACTIVATION;

BRONCHI; DENDRITIC CELLS; HUMANS; IMMUNITY; INTERLEUKINS; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; PULMONARY ALVEOLI; RESPIRATORY SYSTEM;

EID: 0032991632     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029329     Document Type: Review

References (75)

1. Widdicombe JG: Relationship between the composition of mucus, epithelial lining liquid, and adhesion of micro-organisms. Am J Crit Care Med 1995;151:2088-2093.
2. Puchelle E, Girod-de Bentzmann S, Jacquot J: Airway defence mechanisms in relation to biochemical and physical properties of mucus. Eur Respir Rev 1992;2:259-263.
3. Jacquot J, Puchelle E, Zahm JM, Beck G, Plotkowski MC: Effect of human airway lysozyme on the in vitro growth or type 1. Streptococcus pneumoniae. Eur J Respir Dis 1987;71:295-305.
4. Ellison RT III, Giehl TJ: Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991;88:1080-1091.
5. Persson CG: Plasma exudation from tracheobronchial microvessels in health and disease; in Butler J (ed): The Bronchial Circulation. New York, Dekker, 1992, pp 443-473.
6. Wilson R, Pitt T, Taylor G, Watson D, Mac-Dermot J, Sykes D, Roberts D, Cole P: Pyocyanine and 1-hydroxyphenazine products by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest 1987;79:221-229.
7. Boat TF, Boucher RC: Cystic fibrosis; in Murray JF, Nadel JA (eds): Textbook of Respiratory Medicine. Philadelphia, Saunders, 1994, vol 1, pp 1418-1450.
8. Mercer RR, Russell ML, Roggli VL, Crapo JD: Cell number and distribution in human and rat airways. Am J Respir Cell Mol Biol 1994;10: 613-624.
9. Sanderson MJ, Chow I, Dirksen ER: Intercellular communication between ciliated cells in culture. Am J Physiol 1988;254:C63-C74.
10. Sanderson MJ, Charles AC, Boitano S, Dirksen ER: Mechanisms and function of intercellular calcium signaling. Mol Cell Endocrinol 1994; 98:173-187.
11. Barhoumi R, Bowen JA, Stein LS, Echols J, Burghardt RC: Concurrent analysis of intracellular glutathione content and gap junctional communication. Cytometry 1993;14:747-756.
12. Plopper CG, Mariassy AT, Wilson DW, Alley JL, Nishio SJ, Nettesheim P: Comparison of nonciliated tracheal epithelial cells in six mammalian species: Ultrastructure and population densities. Exp Lung Res 1983;5:281-294.
13. Holtzman MJ: Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol 1992; 54:303-329.
14. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M: Release of interleukin-8, interleukin-6 and colony-stimulating factors by upper airway epithelial cells: Implications for cystic fibrosis. Am J Respir Cell Mol Biol 1993;9:455-462.
15. Massion PP, Inoue H, Richman-Eisenstat J, Grunberger D, Jorens PG, Housset B, Pittet JF: Novel pseudomonas product stimulates interleukin-8 production in airway epithelial cell in vitro. J Clin Invest 1994;93:26-32.
16. Choi AM, Jacoby DB: Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett 1992; 309:327-329.
17. Adler KB, Fischer BM, Wright DT, Cohn LA, Becker S: Interactions between respiratory epithelial cells and cytokines: Relationships to lung inflammation. Ann NY Acad Sci 1994; 725:128-145.
18. Center DM, Kornfeld H, Cruikshank W: Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476-478.
19. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
20. Rossi GA, Sacco O, Balbi B, Oddera S, Mattioni T, Corte G, Ravazzoni C, Allegra L: Human ciliated bronchial epithelial cells: Expression of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol 1990;3:431-439.
21. Underdown BJ, Schiff JM: Immunoglobulin A: Strategic defence at the mucosal surface. Annu Rev Immunol 1986;4:389-417.
22. Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM: Dendritic cells with antigen presenting capability reside in airway epithelium, lung parenchyma and visceral pleura. J Exp Med 1986;163:436-451.
23. Holt PG, Haining S, Nelson DJ, Sedgwick JD: Origin and steady-state turnover of class II MCH-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994; 153:256-261.
24. Brokaw JJ, White GW, Baluk P, Anderson GP, Umemoto EY, McDonald DM: Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol 1998;19:598-605.
25. McWilliam AS, Nelson D, Thomas JA, Holt PG: Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 1994;179:1331-1336.
26. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P: Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: Functional and morphological studies. J Exp Med 1987;166:1654-1667.
27. Nicod LP, El Habre F: Adhesion molecules on human lung dendritic cells and their role for T-cell activation. Am J Respir Cell Mol Biol 1992;7:207-213.
28. Fournier MF, Lebargy F, Le Roy Ladurie F, Lenormand E, Pariente R: Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 1989;140:737-742.
29. Azzawi M, Bradley B, Jeffrey PK, Frew AJ, Wardlaw AJ, Assoufi B, Collins JV, Durham S, Kay AB: Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407-1413.
30. 1. Am J Respir Crit Care Med 1997;155:852-857.
31. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Felin WG, Lepper H: Differential production of interferon-gamma and interleukin-4 in response to Th1-and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995;373:255-257.
32. Reynolds HY: Integrated host defence against infections; in Crystal RG, West JB, Weibel ER, Barnes P (eds): The Lung: Scientific Foundations, ed 2. Philadelphia, Lippincott-Raven, 1997.
33. Pabst R, Gehrke I: Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol 1990;3:131-135.
34. Weisz-Carrington P, Grimes SR Jr, Lamm ME: Gut-associated lymphoid tissue as source of an IgA immune response in respiratory tissues after oral immunization and intrabronchial challenge. Cell Immunol 1987;106:132-138.
35. Bergmann KC, Waldman RH: Stimulation of secretory antibody following oral administration of antigen. Rev Infect Dis 1988;10:939-950.
36. Thepen T, Claassen E, Hoeben K et al: Migration of alveolar macrophages from alveolar space to paracortical T cell area of the draining lymph node. Adv Exp Med Biol 1993;329:305-310.
37. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defence and injury: Slate of the art. Am Rev Respir Dis 1990;141:471-501.
38. Ezekowitz RA, Williams DJ, Koziel H, Armstrong MY, Warner A, Richards FF, Rose RM: Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991;351:155-158.
39. Brown EJ: Complement receptors and phagocytosis. Curr Opin Immunol 1991;3:76-82.
40. Galve-de Rochemonteix B, Nicod LP, Dayer JM: Tumor necrosis soluble receptor 75: The principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon γ. Am J Respir Cell Mol Biol 1996;14:279-287.
41. Nicod LP, El Habre F, Dayer JM, Boehringer N: Interleukin-10 decreases tumor necrosis factor a and P in alloreactions induced by human lung dendritic cells and macrophages. Am J Respir Cell Biol 1995;13:83-90.
42. Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG: Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-388.
43. Hamacher J, Sadallah S, Schifferli JA, Villard J, Nicod LP: Soluble complement receptor type I (CD35) in bronchoalveolar lavage of inflammatory lung diseases. Eur Respir J 1998;11: 112-119.
44. Nicod LP, Isler P: Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997;17:91-96.
45. Toews GB, Vial WC, Dunn MM, Guzzetta P, Nunez G, Stastny P, Lipscomb MF: The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 1984;132:181-186.
46. Metzger ZVI, Hoffeld JT, Oppenheim J J: Macrophage-mediated suppression. J Immunol 1980;124:983-988.
47. Isler P, Galve-de Rochemonteix B, Songeon F, Boehringer N, Nicod P: Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. In press.
48. O'Neil SJ, Lesperance E, Klass DJ: Human lung lavage surfactant enhances staphylococcal phagocytosis by alveolar macrophages. Am Rev Respir Dis 1984;130:1177-1179.
49. Laurenzi GA, Potter RT, Kass EH: Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961;265:1273-1278.
50. Reynolds HY, Newball HH: Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974;84:559-573.
51. Merrill WW, Naegel GP, Olchowski JJ, Reynolds HY: Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects: Quantitation and comparison with immunoglobulins A and E. Am Rev Respir Dis 1985;131:584-591.
52. 2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980;303:178-182.
53. Gross GN, Rehm SR, Pierce AK: The effect of complement depletion on lung clearance of bacteria. J Clin Invest 1978;62:373-378.
54. Robertson J, Coldwell JR, Castle JR, Waldman RH: Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol 1976;117:900-903.
55. Weissler JC, Nicod LP, Lipscomb MF, Toews GB: Natural killer cell function in human lung is compartmentalized. Am Rev Respir Dis 1987;135:941-949.
56. Medzhitov R, Janeway CA Jr: Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 1997;9/1:4-9.
57. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
58. + T cells producing IL-2 or IL-4. J Immunol 1992;148:1031-1036.
59. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A: Immunoregulation of cutaneous leishmaniasis. J Exp Med 1988;168:1675-1684.
60. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260: 547-549.
61. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon-γ gene disrupted mice. J Exp Med 1993;178:2243-2247.
62. Flesch I, Kaufmann SHE: Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential suceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-4413.
63. Chensue SW, Terebuh PD, Warmington KS, Hershey SD, Evanoff HL, Kunkel SL, Higashi GI: Role of IL-4 and IFN-γ in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function. J Immunol 1992;148:900-906.
64. Wyde PR, Cate TR: Cellular changes in lungs of mice infected with influenza virus: Characterization of the cytotoxic responses. Infect Immun 1978;22:423-429.
65. Onofrio JM, Toews GB, Lipscomb MF, Pierce A: Granulocyte-alveolar macrophage interactions in the pulmonary clearance of Staphylococcus aureus. Am Rev Respir Dis 1983;127: 335-341.
66. Toews GB, Vial WC, Hansen EJ: Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs. Infect Immun 1985;50:207-212.
67. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
68. Valone FH, Franklin M, Sun GG et al: Alveolar macrophage lipoxygenase products of arachidonic acid: Isolation and recognition as the predominant constituents of the neutrophil chemotactic activity elaborated by alveolar macrophages. Cell Immunol 1985;54:390-401.
69. Villard J, Dayer-Pastore F, Hamacher J, Aubert JD, Schlegel-Haueter S, Nicod LP: GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome, Am J Respir Crit Care Med 1995;152:1549-1554.
70. Burnett D: Neutrophils. Pulmonary Defences. Chichester, Wiley, 1997.
71. Barbosa MD, Barrat FJ, Tchernev VT, Nguyen QA, Mishra VS, Colman SD, Pastural E, Dufoureq-Lagelouse R, Fischer A, Holcombe RF, Wallace MR, Brandt SJ, de Saint Basile G, Kingsmore S: Identification of mutations in two major mRNA isoforms of the Chédiak-Higashi syndrome gene in human and mouse. Hum Mol Genet 1997;7:1091-1098.
72. Curnette JT, Whitten DM, Babior BM: Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 1974;290:593-597.
73. von Adrian UH, Berger EM, Ramezani L, Chambers JD, Ochs HD, Harlan JM, Paulson JC, Etzioni A, Arfors K: In vivo behaviour of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J Clin Invest 1993;91:2893-2897.
74. Walsh GM, Wardlaw AJ: Eosinophils. Pulmonary Defences. Chichester, Wiley, 1997.
75. Levine S: Bronchial epithelial cell-cytokine interaction in airway inflammation. J Invest Med 1995;43:241-249.